Abiopharma

🔍 WYCOFF W KIRK (Executive)

Company: USCB FINANCIAL HOLDINGS, INC. (USCB)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Sold 37,152 shares of Class A Voting Common Stock at $18.24 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,826,634.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 12,848 shares of Class A Voting Common Stock at $18.28 per share (Direct)
  Date: 2026-05-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,813,786.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Holds 4,000 shares of Option to Purchase Class A Voting Common Stock at $11.35 per share (Derivative)
  Date: 2026-04-30 | Code: H | Exercise: 2019-09-23 | shares_owned_after: 4,000.00 | Footnotes: F8, F8

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.20 to $18.57, inclusive. The reporting persons undertake to provide to USCB, any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.50, inclusive. The reporting persons undertake to provide to USCB, any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
• F3: This Form 4 is filed jointly by Patriot Financial Partners GP II, LLC ("Patriot LLC"), Patriot Financial Partners GP II, LP. ("Patriot GP"), Patriot Financial Partners II, LP. ("Patriot Fund II"), Patriot Financial Partners Parallel II, LP. ("Patriot Parallel Fund II," together with Patriot Fund II, the "Funds"), Patriot Financial Manager, LLC ("Manager LLC") and Patriot Financial Manager, L.P. ("Manager LP"), W. Kirk Wycoff, James J. Lynch, Ira M. Lubert and James F. Deutsch.
• F4: Patriot GP is a general partner of each of the Funds and Patriot LLC is a general partner of Patriot GP. In addition, each of W. Kirk Wycoff, Ira M. Lubert and James J. Lynch serve as general partners of the Funds and is a member of Patriot LLC. Manager LP, serves as investment manager to the Funds. Manager LLC serves as general partner of Manager LP and W. Kirk Wycoff, Ira M. Lubert and James J. Lynch are members of Manager LLC. James F. Deutsch is a member of the Patriot Funds Investment Committee.
• F5: The securities owned by the Funds may be regarded as being beneficially owned by Patriot GP, Patriot LLC, Manager LLC, Manager LP, W. Kirk Wycoff, James J. Lynch, Ira M. Lubert and James F. Deutsch.
• F6: After the sales, Manager LP holds 7,500 shares of common stock, Patriot Fund II holds 1,617,670 shares of common stock and Patriot Parallel Fund II holds 188,616 shares of common stock.
• F7: This filing shall not be deemed an admission that the Reporting Persons are subject to Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or, for purposes of Section 16 of the Exchange Act or otherwise (other than to the extent a Reporting Person directly holds the securities reported herein), and Messrs. Wycoff, Lynch, Lubert and Deutsch each disclaim beneficial ownership of the securities owned by the Funds or Manager LP, except to the extent of their respective pecuniary interest therein.
• F8: The option was previously granted to Mr. Wycoff as a director of the Company. The option to purchase Class A Voting Common Stock remains exercisable until three months after the date Mr. Wycoff ceased to serve as a non-employee of the Issuer.